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Abstract L-Asparaginase (E.C. 3.5.1.1) is used as an anti-
neoplastic drug in the treatment of acute lymphoblastic
leukemia. L-Asparaginase from Pseudomonas fluorescens
was cloned and overexpressed in E. coli BL21. The
Enzyme was found to be a Fusion protein-asparaginase
complex which was given a lysozyme treatment and
sonication, and then was purified in a Sepharose 6B col-
umn. The enzymatic properties of the recombinant enzyme
were studied and the kinetic parameters were determined
with kilometre of 109.99 mM and Vmax of 2.88 lM/min.
Recombinant enzyme showed pH optima at 6.3 and tem-
perature optima at 34 C. Asp gene was successfully
cloned into E. coli BL21 which produced high level of
asparaginase intracellularly with 85.25 % recovery of en-
zyme with a specific activity of 0.94 IU/mg protein. The
enzyme was a tetramer with molecular weight of ap-
proximately 141 kDa.
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Introduction
L-Asparaginase enzymes (L-asparagine amidohydrolase)
catalyse the hydrolysis of L-asparagine to L-aspartate and
ammonia, and to a lesser extent, the hydrolysis of L-glu-
tamine to L-glutamate (Ebrahiminezhad et al. 2011). Bacte-
rial L-asparaginase are of two types: type 1 and type 2; type 2
showed antitumor activity because of which interest in L-
asparaginase arose (Lee et al. 1989). Normal cells can syn-
thesize L-asparaginase and because of their ability to produce
this amino acid, normal cells are protected from L-as-
paraginase starvation unlike tumor cellswhich are dependent
on an exogenous supply (Oza et al. 2011). Depletion of the
circulating L-asparaginase by L-asparaginase enzyme results
in anti-neoplastic activity. However, Escherichia coli and
Erwinia sp. enzymes have been frequently used in cancer
therapy (Avramis and Panosyan 2005).
L-Asparaginase from bacterial origin can cause hyper-
sensitivity in the long term used, leading to allergic reactions
and anaphylaxis. The toxicity is partially attributable to the
glutaminase activity of these enzymes (Oza et al. 2011). L-
Asparaginases with high asparaginase activity and negligi-
ble glutaminase activity are reported to be less troublesome
during the course of antitumor therapy (Hawkins et al. 2004).
The search for other asparaginase sources, with new im-
munological characteristics can lead to enzyme with less
adverse effects. Furthermore, new studies have revealed
potential application of this enzyme in prevention of acry-
lamide formation in fried potatoes and similar food products.
Therefore, introduction of new fermentation and purification
protocols for production of L-asparaginase II will be
mandatory to satisfy these demands (Aghaeepoor et al.
2011). So, in this study we will be describing the cloning,
expression, purification and characterization of recombinant
L-asparaginase from P. fluorescens into E. coli BL21.
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L-Asparaginase-specific primers used in this study were
synthesized by Sigma-Aldrich Co (India). Taq polymerase
and dNTPs were procured from Bangalore Genei (India)
Pvt. Ltd. and pET101 TOPO vector kit was obtained from
Invitrogen (India). L-Asparagine and Lysozyme was ob-
tained from Sisco Research Laboratories Pvt. Ltd, Mumbai.
Sonicator used was manufactured by Qsonica and Fer-
menter was designed and manufactured by CFTRI. E. coli
BL21, E. coli DH5a and Pseudomonas fluorescens isolates
were precured from CSIR-CFTRI, Mysore.
DNA isolation and synthesis
Pseudomonas fluorescens was inoculated into induced
50 ml broth and was grown overnight followed by cen-
trifuging and washing thoroughly with sterile distilled
water to remove all traces of broth and extraneous material.
Extraction of DNA was carried out using Lysozyme solu-
tion. Sequences homologous to ASP were sought in the
NCBI using BLAST. A DNA sequence of L-asparaginase
from P. fluorescens (GI no: 255961261) was used for pri-
mer synthesis. PCR was used to amplify the full-length
DNA. The DNA synthesis was carried out in a total volume
of 25 ll, containing 1 ll of DNA templet, 1 ll each of
both forward and reverse primer, 0.3 ll taq polymerase,
0.5 ll dNTP mix, 2.5 ll PCR Buffer and 18.7 ll milli q
water. The PCR procedure comprised 30 cycles of 30 s at
94 C, 1 min at 63.6 C and 30 s at 72 C. A final exten-
sion time at 72 C for 10 min was performed after the 30
cycles. The resulting PCR amplicon was sequenced.
Cloning of ASP gene
For cloning, the primers were designed in such amanner that
they included the CACC sites at 50 end of the PCR amplicon,
so it can be used for TOPO PET101 vector. The forward
primer PFVJF3: 50-CACCATGACATGTGCTTTGAA
GAGTTTCGTCCGG-30 and the reverse primer PFVJR4: 50-
TCAGTATTCCCAGAACATCCGTTGCAGCTC-30 was
used. The resulting amplified PCR amplicon was obtained
through PCR with the conditions mentioned above. The
amplified product was cloned with the plasmid vector
pET101. The cloned vector was transformed to competent
E. coliDH5a cells. The transformedE. coli cells were grown
into LB agar plate containing 100 lg/ml ampicillin, IPTG
and X-gal. The recombinant clones were identified by blue/
white selection and grown at 37 C in 50 ml LB medium
containing 100 lg/ml ampicillin. The plasmid was isolated
from E. coli DH5a and was used to transform competent
E. coli BL21 cells which were screened with blue/white
selection.
Pilot fermentation
The cells were grown into LB agar plate containing
ampicillin. Scale up of recombinant clones was done for
6 L medium for fermentation in 10 L fermenter. The re-
combinant clones were grown in LB medium containing
ampicillin (100 lg/ml) at fermentation conditions of 37 C
with agitation of 180 rpm and aeration of 2 vvm. Synthesis
of asparaginase was induced by the addition of 1 mM IPTG
after 6–8 h of growth.
Purification of asparaginase
Purification of asparaginase was done 16 h after induction
by IPTG, cells were harvested by centrifugation at
6000g for 3 h. Cells obtained after harvesting were resus-
pended into 15 mM phosphate buffer with pH 6.3,
grounded manually with sterile sand and centrifuged at
10,000g for 15 min at 4 C. The supernatant was collected
and used for purification. The fusion protein purification
was done by treatment with 2 mg/ml lysozyme for 2 h and
then sonication at 60 % amplitude for 5 min with 30 s
burst. After sonication, the extract was centrifuged at
10,000g for 30 min at 4 C. The extracted solution was
then loaded to a pre-equilibrated Sepharose 6B column
(1 9 20 cm) with mobile phase 15 mM phosphate buffer
with pH 6.3 (Gladilina et al. 2009). The fractions collected
(2 ml) were assayed for asparaginase activity. The purified
enzyme was dialyzed to remove salt.
Estimation of ASNase activity
Asparaginase assay for native and modified ASNases was
performed for the formation of b-aspartylhydroxamate
(Ramakrishnan and Joseph 1996). Authentic b-aspartyl-
hydroxamate was employed as a standard. One unit (U) of
asparaginase is defined as the amount of enzyme that
formed 1 lmol of b-aspartylhydroxamate in 1 min under
assay conditions. The specific activity is expressed as
U/mg/min of protein. Protein content was measured ac-
cording to (Bradford 1976) using BSA as a standard.
Kinetic analysis
Determination of kinetic constants
Steady-state kinetic measurements were performed to ob-
tain kinetic constants Km and Vmax, of the purified L-as-
paraginase were determined by the method of Lineweaver
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and Burk (1934) with different concentrations (0.5 mM–
1 M) of L-asparagine as a substrate at room temperature
using sodium phosphate buffer (15 mM, pH 6.3).
Effect of pH and temperature on enzyme activity
The effect of pH on purified enzyme was investigated in
the pH range 5.0–9.0 (using 15 mM sodium acetate buffer
for pH 5.0–6.0, sodium phosphate buffer for pH 7.0–8.0
and carbonate-bicarbonate buffer for pH 9.0). The enzyme
was incubated in these buffers for 1 h and the assay was
carried out as given above. The optimal temperature for L-
asparaginase activity of the purified enzyme was measured
by incubating the enzyme-substrate mixtures for 1 h at
various temperatures (8–45 C) at pH 6, and the liberated
ammonia and b-aspartylhydroxamate were measured.
Effect of macro-nutrients on L-asparaginase activity
Macro-nutrients including sodium (NaCl), potassium
(KCl), magnesium (MgCl2), iron (FeCl3) and calcium
chloride (CaCl2) at 1 mM were evaluated for their effect on
L-asparaginase activity by incubating the enzyme at opti-
mum pH and temperature for 1 h, and then ASNase activity
was assayed by estimating the product formed at 500 nm.
Relative activities were calculated and compared with the
native ASNase.
Thermal stability and half-life of cloned ASNase
To study the thermal stability of ASNase, the cloned en-
zyme was incubated at 28 C (room temperature) and
37 C in the absence of the substrate. At periodic intervals,
aliquots were withdrawn and assay was performed as de-
scribed above. The residual activity was expressed as
percent of the initial activity. The inactivation rate con-
stants (kd) were calculated from slopes of a semi-
logarithmic plot of residual activity versus time, and ap-
parent half lives were estimated using Eq. (1). The time
where the residual activity reaches 50 % is known as the
half-life (Kishore et al. 2014).
t1=2 ¼ ln 2ð Þ=kd ð1Þ
Results
Cloning and expression of ASP gene
The DNA yield obtained through Lysozyme method from
Pseudomonas fluorescens was of good quantity and suit-
able for further use. The DNA was used as a template for
synthesizing and amplifying desired L-asparaginase DNA
by PCR and the PCR amplicon was purified. To select the
required expression product, pET101 vector was chosen.
The amplified product was checked for the presence of
gene of interest by using the desired primers by PCR. The
fusion plasmid with gene was used to initially transform
into E. coli DH5a. The plasmid from E. coli DH5a cells
was purified and used to transform expression host E. coli
BL21. Cell-free extract of the E. coli BL21 gave fusion
protein-asparaginase complex with a total protein content
of 2.16 mg protein/ml.
Purification of asparaginase
Fusion protein-asparaginase complex was given a lyso-
zyme treatment and sonication, and was then purified in a
one-step procedure (Table 1). In the purification scheme, a
Sepharose 6B column was used. Pre-treated enzyme extract
was applied directly to the Sepharose column equilibrated
with 15 mM phosphate buffer pH 6.3. The enzyme was
obtained as per size exclusion and was eluted. The as-
paraginase activity was shown by fractions with a specific
activity of 11.6 IU/mg protein. The purity of the final as-
paraginase was evaluated by SDS-PAGE, which showed
that the Asparaginase is a tetramer with molecular weight
of the cloned product around 141 kDa (Fig. 1).
Kinetic analysis results
Determination of kinetic constants
Steady-state kinetic measurements were performed ac-
cording to ‘‘Materials and methods’’, Michaelis–Menten
plot was done (Fig. 2) and kinetic constants Km was found
to be 109.99 mM and Vmax was 2.88 lM/min.
Effect of pH on enzyme activity
Since microorganisms are sensitive to the concentration of
hydrogen ions present in the medium, pH is considered as
an important factor that determines the growth, mor-
phology and product formation. Effect of pH was studied in
range of 5–9 according to ‘‘Materials and methods’’ and it
was observed that the optimum pH was 6.3 (Fig. 3).
Effect of temperature on enzyme activity
After obtaining the optimum pH for enzyme, the ex-
periments were run at phosphate buffer pH of 6.3 at dif-
ferent temperatures from 8 to 45 C according to
‘‘Materials and methods’’ and it was observed that enzyme
activities at 8 C was low, and there was a gradual increase
in activity with increase in temperature up to 34 C which
was found to be optimum temperature (Fig. 4). Further rise
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in temperature would have led to the degradation of en-
zyme and thermal deactivation; hence there is a decrease in
enzyme activity.
Effect of metal ions
Effect of few metal ions was studied according to ‘‘Mate-
rials and methods’’. With the cloned enzyme, not much
inhibitory effect was seen on the enzyme activity
(Table 2). The activity of control cloned enzyme was
similar to the enzyme in the presence of metal ions.
Half-life of asparaginase
The enzyme assay was done and half-life was calculated
according to ‘‘Materials and methods’’ at 28 C (room
Table 1 Purification of recombinant L-asparaginase from E. coli
Sample Volume (ml) Protein (mg) Activity (IU) Specific activity (IU/mg) Fold purification Recovery (%)
Cell-free extract 30 198 2.38 0.012 0 0
Lysozyme treated and sonicated 30 270 157 0.58 1 100
Sepharose column 300 140.88 133.84 0.95 1.64 85.25
IU is international units for enzyme activity
Fig. 1 SDS-PAGE of recombinant L-asparaginase having crude
sample, purified sample and Marker. L-Asparaginase was found to
be a tetramer having 4 monomers of sizes 21, 35, 40 and 45 kDa after






















































Fig. 4 Effect of temperature on L-asparaginase activity at pH 6.3
978 3 Biotech (2015) 5:975–981
123
temperature) and 37 C (Table 3). Half-life of cloned en-
zyme was found to be 35 h at 28 C and 45.5 h at 37 C.
Discussion
In the present study, we have produced L-asparaginase by
cloning the asparaginase gene from Pseudomonas sp. into
E. coli, for that we started our work with isolation of DNA,
primer designing for asparaginase gene, cloning into
pET101 for expression and pTZ57 R/T vector for se-
quencing, expression of the Asparaginase gene into E. coli
BL21, obtaining large quantity of enzyme using 10 L fer-
menter, purifying the enzyme and finally characterizing the
cloned purified Asparaginase was carried out. Recombinant
L-asparaginase was developed by cloning L-asparaginase
from Erwinia carotovora NCYC 1526 (Er A) and ex-
pressing in E. coli. The enzyme was purified by anion-
exchange chromatography and affinity chromatography on
immobilized asparagine (Kotzia and Labrou 2005). Re-
combinant L-asparaginase has been produced by the use of
molecular cloning and genetic engineering techniques.
E. coli mutants resistant to substrate L-asparaginase were
studied by Spring et al. (1986). It was found that the genes
encoding L-asparaginase-I and L-asparaginase-II were not
sequence related.
Cloning of E. coli gene ansB encoding L-asparaginase-II,
using strategy based on PCR, and sequencing the gene
was discussed by Bonthron (1990). The amino acid se-
quence differed from 11 positions from the data previously
derived by direct amino acid sequencing. Expression of L-
asparaginase-II encoded by ansB in Salmonella enterica
was found to be positively regulated by a cAMP receptor
protein (cRP) and anaerobiosis (Jennings and Beacham
1993). Abundance of AS mRNA was measured by RQ-
PCR as reported by Irino et al. (2007), the AS mRNA level
paralleled the AS enzyme activity and the AS protein level.
Cellular levels of AS synchronized with cellular resistance
to L-asparaginase in cell lines. Recombinant L-asparaginase
from Erwinia carotovora, and purified by 1-step chro-
matography, was described by Krasotkina et al. (2004).
The kinetic properties showed that recombinant L-as-
paraginase combined the main advantages of Erwinia
chrysanthemi and E. coli L-asparaginase-II. L-asparaginase
from Erwinia chrysanthemi 3937 (Erl-ASNase) has been
expressed in E. coli BL21 (DE3) pLysS (Kotzia and Lab-
rou 2007). The enzyme was found to be a tetramer with
molecular weight of approximately 141 kDa. It had a pH
optima at 6.3 and temperature optima of 34 C with Km of
109.99 mM and Vmax of 2.88 lM/min. Its activation en-
ergies were found to be dependent on the substrate. The L-
asparaginase-II functional form exists as tetramer in
Pseudomonas geniculate (Kitto et al. 1979) and E. coli
(Khushoo et al. 2004) with molecular mass range from 140
to 160 kDa (Aghaiypour et al. 2001, El-Naggar et al.
2014). The L-asparaginase gene of E. coli alpha-acetyl
actate decarboxylate gene (ALDC) of B. brevis were am-
plified by PCR and cloned into a new vector transformed
into S. cerevisiae. Most of the enzyme activities were se-
creted into the medium and the new vectors had excellent
segregation stability (Zhao et al. 2002). The enzymatic and
structural properties of the recombinant enzyme were in-
vestigated and the kinetic parameters [Km, Kcat] for a
number of substrates were determined. The enzyme was
later immobilized on epoxy-activated Sepharose CL-6B as
described by Gladilina et al. (2009) who have taken SP-
Sepharose (2.5 9 10 cm) equilibrated with 20 mM potas-
sium phosphate buffer, pH 5.8. The immobilized enzyme
retained most of its activity (60 %) and showed high sta-
bility at 4 C. L-Asparaginase II gene isolated from ther-
motolerant E. coli strain, cloned in pET20b vector with
6His residues at a c-terminus downstream to the T7 pro-
moter and pelB leader sequence, and biochemically char-
acterized. Apart from clinical use, this enzyme can be used
in fried starchy food preparation to reduce the acrylamide
content, a potent carcinogen formed during the baking
process by the reaction of asparaginase and sugar at hight
temperature (Muharram et al. 2014). Application of mi-
crobial Lasparaginase in reducing acrylamide formation
during the bread-making process, without affecting its
physico-sensory properties and play an important role in
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reducing the formation of acrylamide. Reduction of toxic
metabolites like acrylamide and HMF, i.e., Hydrox-
ymethylfurfural (another toxic Maillard reaction com-
pound) formed during baking, was also reduced by L-
asparaginase treatment. The enzyme-treated bread was
same as control bread with respect to organoleptic prop-
erties. This opens avenues for the application of microbial
enzymes in obtaining safe foods (Mohan Kumar et al.
2014).
Cloning of E. coli gene ansB encoding L-asparaginase-
II, using strategy based on PCR, and sequencing the gene
was discussed by (Bonthron 1990). The amino acid se-
quence differed from 11 positions from the data previously
derived by direct amino acid sequencing. Expression of L-
asparaginase-II encoded by ansB in Salmonella enterica
was found to be positively regulated by a cAMP receptor
protein (cRP) and anaerobiosis (Jennings and Beacham
1993).
Conclusion
The cloned enzyme was studied for its stability at 28 C
(room temperature) and at 37 C, and it was observed that
the cloned Asparaginase was stable with a half-life of 35 h
at 28 C (room temperature) and 45.5 h at 37 C. Cloned
Asparaginase was better in terms of activity and stability at
37 C. This enzyme could be used/stored for longer time
periods at room temperature for experiments relating to
acrylamide reduction in food products. Also, its higher
half-life at 37 C makes it a more suitable enzyme to be
used against cancerous cells.
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